US$ 22.51
retatrutide lilly Antigua Lindsay Maggio, MD, MPH |
Description
We do not know whether tirzepatide specifically, with its dual GIP and GLP-1 action, offers migraine benefits beyond what pure GLP-1 agonists provide
What were the main results

Safety data in humans remain scarce, and caution is strongly advised

And there may be some people previously unresponsive to existing therapies who would benefit from trying orforglipron instead

Retrieved August 5, 2024

Not Sure Where to Start
